Retinoblastoma in the perinatal and neonatal child

Research output: Contribution to journalReview articlepeer-review

22 Scopus citations


Retinoblastoma is a rare primary intraocular malignancy. Presentation in the neonatal period is not common. With improved genetic testing, screening of the unborn child and neonate is taking on a greater role in the management of these patients. Treatment of retinoblastoma in the neonate is complex and requires a multidisciplinary and highly individualized approach. If possible, focal modalities should be used and external beam radiation avoided. Systemic intravenous chemotherapy may be necessary with regimens including carboplatin, vincristine and etoposide. Such cases are best managed by specialist centers with access to experts in oncology, ophthalmology, radiation therapy, genetics, pathology and anesthesia.

Original languageEnglish (US)
Pages (from-to)239-242
Number of pages4
JournalSeminars in Fetal and Neonatal Medicine
Issue number4
StatePublished - Aug 2012


  • Eye
  • Neonatal
  • Periocular chemotherapy
  • Retinoblastoma
  • Screening

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health


Dive into the research topics of 'Retinoblastoma in the perinatal and neonatal child'. Together they form a unique fingerprint.

Cite this